Biosimilar-Substitution Restrictions Head To Pa. Senate

16-11-2013 Law360Comments (0)


A Pennsylvania Senate committee on Wednesday advanced legislation that would restrict substitution of biosimilars for their brand-name counterparts, one of many comparable bills that are moving ...

Read more on Law360

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top